Clinical Trial Update: Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for Cadonilimab in combination with Lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cadonilimab
• LENVIMA (lenvatinib)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING